Impact of TP53 mutation variant allele frequency on phenotype and outcomes in myelodysplastic syndromes
|
Oct 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Epigenetics of myelodysplastic syndromes
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
A phase 3 randomized placebo-controlled trial of darbepoetin alfa in patients with anemia and lower-risk myelodysplastic syndromes
|
Jun 2017
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
The myelodysplastic syndromes flow cytometric score: a 3-parameter prognostic flow cytometric scoring system
|
Oct 2015
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Combination of Azacitidine and Lenalidomide in Myelodysplastic Syndromes or acute Myeloid Leukemia-a wise Liaison?
|
May 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
|
Nov 2013
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Impact of somatic mutations on response to lenalidomide in lower-risk non-del(5q) myelodysplastic syndromes patients
|
Jul 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
What causes aplastic anaemia?
|
Apr 2023
|
Leukemia
|
aplastic anemia
|
A clinical trial for patients with acute myeloid leukemia or myelodysplastic syndromes not eligible for standard clinical trials
|
Oct 2016
|
Leukemia
|
myelodysplastic syndromes (MDS)
|
Letter to the Editor: Allogeneic hematopoietic stem cell transplantation in elderly patients with acute myeloid leukemia or myelodysplastic syndromes: myth and reality
|
Jul 2020
|
Leukemia
|
myelodysplastic syndromes (MDS)
|